Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.74 - $1.83 $303 - $750
410 Added 1.25%
33,194 $29,000
Q3 2022

Nov 09, 2022

BUY
$1.51 - $2.88 $866 - $1,653
574 Added 1.78%
32,784 $51,000
Q2 2022

Aug 08, 2022

BUY
$1.24 - $2.33 $10,158 - $19,087
8,192 Added 34.11%
32,210 $65,000
Q1 2022

May 03, 2022

BUY
$2.0 - $4.9 $17,408 - $42,649
8,704 Added 56.84%
24,018 $56,000
Q4 2021

Feb 14, 2022

BUY
$4.65 - $7.23 $5,003 - $7,779
1,076 Added 7.56%
15,314 $71,000
Q3 2021

Nov 12, 2021

BUY
$7.41 - $10.99 $29,254 - $43,388
3,948 Added 38.37%
14,238 $109,000
Q2 2021

Aug 16, 2021

BUY
$6.35 - $10.0 $65,341 - $102,900
10,290 New
10,290 $100,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Acorn Wealth Advisors, LLC Portfolio

Follow Acorn Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorn Wealth Advisors, LLC with notifications on news.